238 related articles for article (PubMed ID: 11805203)
1. Defective intracellular calcium handling in monocrotaline-induced right ventricular hypertrophy: protective effect of long-term endothelin-A receptor blockade with 2-benzo[1,3]dioxol-5-yl-3-benzyl-4-(4-methoxy-phenyl-)- 4-oxobut-2-enoate-sodium (PD 155080).
Brunner F; Wölkart G; Haleen S
J Pharmacol Exp Ther; 2002 Feb; 300(2):442-9. PubMed ID: 11805203
[TBL] [Abstract][Full Text] [Related]
2. Effect of endothelin antagonism on contractility, intracellular calcium regulation and calcium regulatory protein expression in right ventricular hypertrophy of the rat.
Stessel H; Brunner F
Basic Clin Pharmacol Toxicol; 2004 Jan; 94(1):37-45. PubMed ID: 14725613
[TBL] [Abstract][Full Text] [Related]
3. Calcium handling and role of endothelin-1 in monocrotaline right ventricular hypertrophy of the rat.
Wölkart G; Strömer H; Brunner F
J Mol Cell Cardiol; 2000 Nov; 32(11):1995-2005. PubMed ID: 11040104
[TBL] [Abstract][Full Text] [Related]
4. Nonspecific endothelin-receptor antagonist blunts monocrotaline-induced pulmonary hypertension in rats.
Hill NS; Warburton RR; Pietras L; Klinger JR
J Appl Physiol (1985); 1997 Oct; 83(4):1209-15. PubMed ID: 9338430
[TBL] [Abstract][Full Text] [Related]
5. The orally active ET(A) receptor antagonist (+)-(S)-2-(4,6-dimethoxy-pyrimidin-2-yloxy)-3-methoxy-3,3-diphe nyl-propionic acid (LU 135252) prevents the development of pulmonary hypertension and endothelial metabolic dysfunction in monocrotaline-treated rats.
Prié S; Leung TK; Cernacek P; Ryan JW; Dupuis J
J Pharmacol Exp Ther; 1997 Sep; 282(3):1312-8. PubMed ID: 9316840
[TBL] [Abstract][Full Text] [Related]
6. Cardiac endothelin and big endothelin in right-heart hypertrophy due to monocrotaline-induced pulmonary hypertension in rat.
Brunner F
Cardiovasc Res; 1999 Oct; 44(1):197-206. PubMed ID: 10615403
[TBL] [Abstract][Full Text] [Related]
7. Contribution of endogenous endothelin-1 to the progression of cardiopulmonary alterations in rats with monocrotaline-induced pulmonary hypertension.
Miyauchi T; Yorikane R; Sakai S; Sakurai T; Okada M; Nishikibe M; Yano M; Yamaguchi I; Sugishita Y; Goto K
Circ Res; 1993 Nov; 73(5):887-97. PubMed ID: 8403258
[TBL] [Abstract][Full Text] [Related]
8. Activation of the right ventricular endothelin (ET) system in the monocrotaline model of pulmonary hypertension: response to chronic ETA receptor blockade.
Jasmin JF; Cernacek P; Dupuis J
Clin Sci (Lond); 2003 Dec; 105(6):647-53. PubMed ID: 12823096
[TBL] [Abstract][Full Text] [Related]
9. Acceleration of Ca2+ waves in monocrotaline-induced right ventricular hypertrophy in the rat.
Miura M; Hirose M; Endoh H; Wakayama Y; Sugai Y; Nakano M; Fukuda K; Shindoh C; Shirato K; Shimokawa H
Circ J; 2011; 75(6):1343-9. PubMed ID: 21467666
[TBL] [Abstract][Full Text] [Related]
10. Ranolazine prevents INaL enhancement and blunts myocardial remodelling in a model of pulmonary hypertension.
Rocchetti M; Sala L; Rizzetto R; Staszewsky LI; Alemanni M; Zambelli V; Russo I; Barile L; Cornaghi L; Altomare C; Ronchi C; Mostacciuolo G; Lucchetti J; Gobbi M; Latini R; Zaza A
Cardiovasc Res; 2014 Oct; 104(1):37-48. PubMed ID: 25139747
[TBL] [Abstract][Full Text] [Related]
11. The endothelin A receptor antagonists PD 156707 (CI-1020) and PD 180988 (CI-1034) reverse the hypoxic pulmonary vasoconstriction in the perinatal lamb.
Coe Y; Haleen SJ; Welch KM; Liu YA; Coceani F
J Pharmacol Exp Ther; 2002 Aug; 302(2):672-80. PubMed ID: 12130731
[TBL] [Abstract][Full Text] [Related]
12. Glycyrrhizin, inhibitor of high mobility group box-1, attenuates monocrotaline-induced pulmonary hypertension and vascular remodeling in rats.
Yang PS; Kim DH; Lee YJ; Lee SE; Kang WJ; Chang HJ; Shin JS
Respir Res; 2014 Nov; 15():148. PubMed ID: 25420924
[TBL] [Abstract][Full Text] [Related]
13. Roles of endothelin ETA and ETB receptors in the pathogenesis of monocrotaline-induced pulmonary hypertension.
Nishida M; Eshiro K; Okada Y; Takaoka M; Matsumura Y
J Cardiovasc Pharmacol; 2004 Aug; 44(2):187-91. PubMed ID: 15243299
[TBL] [Abstract][Full Text] [Related]
14. Endothelial nitric oxide synthase-enhancing G-protein coupled receptor antagonist inhibits pulmonary artery hypertension by endothelin-1-dependent and endothelin-1-independent pathways in a monocrotaline model.
Liu CP; Dai ZK; Huang CH; Yeh JL; Wu BN; Wu JR; Chen IJ
Kaohsiung J Med Sci; 2014 Jun; 30(6):267-78. PubMed ID: 24835346
[TBL] [Abstract][Full Text] [Related]
15. PRX-08066, a novel 5-hydroxytryptamine receptor 2B antagonist, reduces monocrotaline-induced pulmonary arterial hypertension and right ventricular hypertrophy in rats.
Porvasnik SL; Germain S; Embury J; Gannon KS; Jacques V; Murray J; Byrne BJ; Shacham S; Al-Mousily F
J Pharmacol Exp Ther; 2010 Aug; 334(2):364-72. PubMed ID: 20430844
[TBL] [Abstract][Full Text] [Related]
16. Calcium mishandling impairs contraction in right ventricular hypertrophy prior to overt heart failure.
Power AS; Hickey AJ; Crossman DJ; Loiselle DS; Ward ML
Pflugers Arch; 2018 Jul; 470(7):1115-1126. PubMed ID: 29525825
[TBL] [Abstract][Full Text] [Related]
17. Genistein, a phytoestrogen, attenuates monocrotaline-induced pulmonary hypertension.
Homma N; Morio Y; Takahashi H; Yamamoto A; Suzuki T; Sato K; Muramatsu M; Fukuchi Y
Respiration; 2006; 73(1):105-12. PubMed ID: 16432296
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic efficacy of TBC3711 in monocrotaline-induced pulmonary hypertension.
Kosanovic D; Kojonazarov B; Luitel H; Dahal BK; Sydykov A; Cornitescu T; Janssen W; Brandes RP; Davie N; Ghofrani HA; Weissmann N; Grimminger F; Seeger W; Schermuly RT
Respir Res; 2011 Jun; 12():87. PubMed ID: 21699729
[TBL] [Abstract][Full Text] [Related]
19. Cardioprotective effect of cerium oxide nanoparticles in monocrotaline rat model of pulmonary hypertension: A possible implication of endothelin-1.
Nassar SZ; Hassaan PS; Abdelmonsif DA; ElAchy SN
Life Sci; 2018 May; 201():89-101. PubMed ID: 29588134
[TBL] [Abstract][Full Text] [Related]
20. Short-term administration of a cell-permeable caveolin-1 peptide prevents the development of monocrotaline-induced pulmonary hypertension and right ventricular hypertrophy.
Jasmin JF; Mercier I; Dupuis J; Tanowitz HB; Lisanti MP
Circulation; 2006 Aug; 114(9):912-20. PubMed ID: 16940204
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]